Ratings Pernod Ricard Swiss Exchange

Equities

RI

FR0000120693

Delayed Swiss Exchange Other stock markets 16:36:26 23/08/2022 BST			5-day change	1st Jan Change
188 ^CHF	+2.45%		-.--%	-.--%

01:19pm	Pernod Ricard: concert Paul Ricard over 15% of share capital	CF
06-26	PERNOD RICARD : Deutsche Bank remains Neutral	ZD

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The group's high margin levels account for strong profits.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Analyst opinion has improved significantly over the past four months.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
The company's enterprise value to sales, at 3.62 times its current sales, is high.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Distillers & Wineries

	1st Jan change	Capi.	ESG Refinitiv
PERNOD RICARD	-.--%	33.94B	-
DIAGEO PLC	-12.94%	69.85B	A-
BROWN-FORMAN CORPORATION	-24.36%	20.57B	B
THAI BEVERAGE	-15.24%	8.34B	B
EMPERADOR INC.	-10.79%	5.01B	B-
RÉMY COINTREAU	-31.57%	4.25B	B
ZJLD GROUP INC	-17.72%	3.51B	-
RADICO KHAITAN LIMITED	+7.35%	2.87B	C
FEVERTREE DRINKS PLC	+3.80%	1.6B	C-
TAKARA HOLDINGS INC.	-11.54%	1.32B	B-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes